OBJECTIVES: Meaningful patient engagement (PE) in medicines development requires all stakeholders have a common purpose and vision, and a clear understanding of respective expectations. As phase one of a research project, a qualitative survey was undertaken to understand expectations from stakeholders.

METHODS: The survey explored four key themes from the perspective of each stakeholder group: meaning, views, expectations and priorities for PE. Participants were grouped into 7 broad categories: policymakers/regulators; healthcare professionals (HCPs); research funders; payers/purchasers/HTA; patients/patient representatives; pharmaceutical/life sciences industry; academic researchers.

RESULTS: CONCLUSIONS: To our knowledge this is the first qualitative survey exploring stakeholders’ expectations from PE in medicines development. Despite broad stakeholder categories, clear themes emerged: a desire for effective PE but some discord in alignment, structure and clarity. A Stakeholder Expectations Matrix that summarises findings and provides an ‘action list’ for stakeholders will be presented.